Cardiovascular challenges in the era of antiretroviral therapy for AIDS/ HIV: A comprehensive review of research advancements, pathophysiological insights, and future directions
- 19 December 2023
- journal article
- review article
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (3) , 102353
Abstract
No abstract availableKeywords
Funding Information
- Deanship of Scientific Research, King Khalid University (RGP2/360/44)
This publication has 93 references indexed in Scilit:
- Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic ReviewPLOS ONE, 2013
- Correlation between HIV disease and lipid metabolism in antiretroviral-naïve HIV-infected patients in JapanJournal of Infection and Chemotherapy, 2012
- Cardiovascular implications from untreated human immunodeficiency virus infectionEuropean Heart Journal, 2011
- Antiretrovirals Induce Endothelial Dysfunction via an Oxidant-Dependent Pathway and Promote Neointimal HyperplasiaToxicological Sciences, 2010
- HIV-1 antiretrovirals induce oxidant injury and increase intima–media thickness in an atherogenic mouse modelToxicology Letters, 2009
- Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylationLaboratory Investigation, 2009
- HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAIDS, 2008
- Aging and Infectious Diseases: Workshop on HIV Infection and Aging: What Is Known and Future Research DirectionsClinical Infectious Diseases, 2008
- Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2007
- HIV infection, HAART, and endothelial adhesion molecules: current perspectivesThe Lancet Infectious Diseases, 2004